RxDoctor Payments Data

Todd Fox, MD

Family Medicine · Kansas City, MONPI 1700856358

Payments from drug & device makers

$1,337in general payments, 2019–2025

Across 86 payments — averaging $15.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$327
  • Abbott$173
  • Amgen$112
  • Pfizer$109
  • Biohaven Pharmaceuticals, Inc.$74
  • Novo Nordisk$73
  • plus $469 from 17 others

What the payments were for

  • Food & beverage$1,28796%
  • Other$504%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,337 in reported general payments places this provider in the 65th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$128,452
Medicare patients
458
Services billed
4,657

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide86$86,443
JardianceEmpagliflozin62$68,758
EliquisApixaban54$43,440
TrulicityDulaglutide20$29,904
FarxigaDapagliflozin Propanediol29$25,508
MounjaroTirzepatide17$18,297
Repatha SureclickEvolocumab11$9,209
ShingrixVaricella-Zoster Ge/As01b/Pf41$9,065
AbrysvoRsv Vacc, Pref A And Pref B/Pf26$8,255
SymbicortBudesonide/Formoterol Fumarate23$7,581
Breztri AerosphereBudesonide/Glycopyr/Formoterol12$7,547
Janumet XrSitagliptin Phos/Metformin Hcl13$6,820
PaxlovidNirmatrelvir/Ritonavir35$5,436
Atorvastatin Calcium556$5,147
Potassium Chloride160$3,314

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$73$86,44386 claims
Boehringer IngelheimJardiance$53$68,75862 claims
PfizerEliquis, Abrysvo, Paxlovid$109$57,131115 claims
Lilly USA, LLCTrulicity, Mounjaro$62$48,20037 claims
AstraZenecaFarxiga, Symbicort, Breztri Aerosphere$27$40,63664 claims
GSKShingrix$13$9,06541 claims
MerckJanumet Xr$13$6,82013 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Kansas City

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →